INTRODUCTION: Potential benefit from stem cell treatments has more patients seeking treatment without understanding possible risks. METHODS: We describe a woman who presented with progressive bilateral leg pain, numbness, and gait difficulties. A prior stroke, macular degeneration, osteoarthritis, and depression, led her to receive intrathecal neural stem cell therapy overseas 1 year before onset of symptoms. RESULTS: Imaging showed marked enlargement of lumbosacral roots of the cauda equina, which was not seen before stem cell treatment. Electrodiagnostic studies confirmed chronic multiple lumbosacral radiculopathies. Biopsy of a lumbar dorsal sensory root showed myelinated fiber degeneration and loss, with endoneurial inflammation. The hypertrophic inflammatory cauda equina syndrome was potentially triggered by the prior intrathecal neural stem cell injection. CONCLUSIONS: Safety of intrathecal stem cell treatments is not routinely regulated in overseas stem cell facilities. We wish to bring this potential complication to the attention of health care providers.
INTRODUCTION: Potential benefit from stem cell treatments has more patients seeking treatment without understanding possible risks. METHODS: We describe a woman who presented with progressive bilateral leg pain, numbness, and gait difficulties. A prior stroke, macular degeneration, osteoarthritis, and depression, led her to receive intrathecal neural stem cell therapy overseas 1 year before onset of symptoms. RESULTS: Imaging showed marked enlargement of lumbosacral roots of the cauda equina, which was not seen before stem cell treatment. Electrodiagnostic studies confirmed chronic multiple lumbosacral radiculopathies. Biopsy of a lumbar dorsal sensory root showed myelinated fiber degeneration and loss, with endoneurial inflammation. The hypertrophic inflammatory cauda equina syndrome was potentially triggered by the prior intrathecal neural stem cell injection. CONCLUSIONS: Safety of intrathecal stem cell treatments is not routinely regulated in overseas stem cell facilities. We wish to bring this potential complication to the attention of health care providers.
Authors: Rahul Rahangdale; Sandeep Rana; Prarthana Prakash; Mohammad Ali; Mary Flaherty; Andrea Synowiec; Susan Baser; Thomas Scott Journal: Mov Disord Clin Pract Date: 2019-03-12
Authors: Ajay A Madhavan; Dan Summerfield; Christopher H Hunt; Dong K Kim; Karl N Krecke; Aditya Raghunathan; John C Benson Journal: Neuroradiol J Date: 2020-02-03
Authors: Emily A Sloan; Paul J Sampognaro; Jacqueline C Junn; Cynthia Chin; Line Jacques; Prashanth S Ramachandran; Joseph L DeRisi; Michael R Wilson; Arnold R Kriegstein; Andrew W Bollen; David A Solomon; Marta Margeta; John W Engstrom Journal: Acta Neuropathol Date: 2019-10-28 Impact factor: 17.088
Authors: Jayden A Smith; Alexandra M Nicaise; Rosana-Bristena Ionescu; Regan Hamel; Luca Peruzzotti-Jametti; Stefano Pluchino Journal: Front Cell Dev Biol Date: 2021-07-09
Authors: Aaron D Brumbaugh; Alan Podolsky; Matthew H Kulzer; Michael P Spearman; Michael F Goldberg; Warren M Chang; Nazia Khatoon; Kossivi Dantey; Charles Q Li Journal: Radiol Case Rep Date: 2022-03-15